Cargando…
Immunosuppressive peptides and their therapeutic applications()
The immune system is vital for detecting and evading endogenous and exogenous threats to the body. Failure to regulate this homeostasis leads to autoimmunity, which is often associated with malfunctioning T cell signaling. Several medications are available to suppress over-reactive T lymphocytes, bu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd., Distributed by Virgin Mailing and Distribution
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042018/ https://www.ncbi.nlm.nih.gov/pubmed/24333193 http://dx.doi.org/10.1016/j.drudis.2013.12.002 |
_version_ | 1782318746191265792 |
---|---|
author | Thell, Kathrin Hellinger, Roland Schabbauer, Gernot Gruber, Christian W. |
author_facet | Thell, Kathrin Hellinger, Roland Schabbauer, Gernot Gruber, Christian W. |
author_sort | Thell, Kathrin |
collection | PubMed |
description | The immune system is vital for detecting and evading endogenous and exogenous threats to the body. Failure to regulate this homeostasis leads to autoimmunity, which is often associated with malfunctioning T cell signaling. Several medications are available to suppress over-reactive T lymphocytes, but many of the currently marketed drugs produce severe and life-threatening side-effects. Ribosomally synthesized peptides are gaining recognition from the pharmaceutical industry for their enhanced selectivity and decreased toxicity compared with small molecules; in particular, circular peptides exhibit remarkable stability and increased oral administration properties. For example, plant cyclotides effectively inhibit T lymphocyte proliferation. They are composed of a head-to-tail cyclized backbone and a cystine-knot motif, which confers them with remarkable stability, thus making them attractive pharmaceutical tools. |
format | Online Article Text |
id | pubmed-4042018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier Science Ltd., Distributed by Virgin Mailing and Distribution |
record_format | MEDLINE/PubMed |
spelling | pubmed-40420182014-06-06 Immunosuppressive peptides and their therapeutic applications() Thell, Kathrin Hellinger, Roland Schabbauer, Gernot Gruber, Christian W. Drug Discov Today Review The immune system is vital for detecting and evading endogenous and exogenous threats to the body. Failure to regulate this homeostasis leads to autoimmunity, which is often associated with malfunctioning T cell signaling. Several medications are available to suppress over-reactive T lymphocytes, but many of the currently marketed drugs produce severe and life-threatening side-effects. Ribosomally synthesized peptides are gaining recognition from the pharmaceutical industry for their enhanced selectivity and decreased toxicity compared with small molecules; in particular, circular peptides exhibit remarkable stability and increased oral administration properties. For example, plant cyclotides effectively inhibit T lymphocyte proliferation. They are composed of a head-to-tail cyclized backbone and a cystine-knot motif, which confers them with remarkable stability, thus making them attractive pharmaceutical tools. Elsevier Science Ltd., Distributed by Virgin Mailing and Distribution 2014-05 /pmc/articles/PMC4042018/ /pubmed/24333193 http://dx.doi.org/10.1016/j.drudis.2013.12.002 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Review Thell, Kathrin Hellinger, Roland Schabbauer, Gernot Gruber, Christian W. Immunosuppressive peptides and their therapeutic applications() |
title | Immunosuppressive peptides and their therapeutic applications() |
title_full | Immunosuppressive peptides and their therapeutic applications() |
title_fullStr | Immunosuppressive peptides and their therapeutic applications() |
title_full_unstemmed | Immunosuppressive peptides and their therapeutic applications() |
title_short | Immunosuppressive peptides and their therapeutic applications() |
title_sort | immunosuppressive peptides and their therapeutic applications() |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042018/ https://www.ncbi.nlm.nih.gov/pubmed/24333193 http://dx.doi.org/10.1016/j.drudis.2013.12.002 |
work_keys_str_mv | AT thellkathrin immunosuppressivepeptidesandtheirtherapeuticapplications AT hellingerroland immunosuppressivepeptidesandtheirtherapeuticapplications AT schabbauergernot immunosuppressivepeptidesandtheirtherapeuticapplications AT gruberchristianw immunosuppressivepeptidesandtheirtherapeuticapplications |